These very high amounts of cancer-derived TGF-β in pancreatic cancer patients could account for high rates of CAT incidence [5] as they simultaneously yield high levels of PAI1 and PAI1 activity [21]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.